Webinar on CMS and Affordable Care Act:First of a series of AMCP Member Regulatory Briefings providing an overview of newly proposed regulations and agency guidance relevant to managed care pharmacy Watch RecordingClose
AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.
